Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
In Budget 2017, the Government announced a new vision for Canada to become a global leader in innovation. Sector-specific roadmaps were developed to help support this innovation and the opportunities that innovation presents for growth. Health Canada’s Chief Regulatory Officer David Lee reported on the results of horizon scanning done by his team. The drivers and insights they uncovered led them to legislative solutions, including Agile Regulations.
Director, Regulatory Strategy and Policy
Hoffmann-La Roche Limited
Lisa Chartrand began her career in the industry with Apotex as a quality assurance chemist and found her passion in Regulatory Affairs when she joined EMD Serono in 1999. At Roche Canada since 2003, she has enjoyed many growth opportunities in Regulatory Affairs and Medical Affairs and was appointed Director, Regulatory Affairs in 2014. Lisa is co-chair and an active member of Innovative Medicines Canada's Regulatory Operations Team and a member of BioteCanada's Biologics Regulatory Affairs Group (BRAG). Lisa earned her Bachelors of Science in Microbiology and Immunology from McGill University in Montreal, Quebec and holds a certificate from TIPT in Quality Assurance.